• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oramed Pharmaceuticals Inc. - Common Stock (NQ:ORMP)

3.470 +0.060 (+1.76%)
Streaming Delayed Price Updated: 2:25 PM EST, Feb 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 122,683
Open 3.450
Bid (Size) 3.460 (200)
Ask (Size) 3.470 (200)
Prev. Close 3.410
Today's Range 3.390 - 3.480
52wk Range 1.820 - 3.710
Shares Outstanding 32,514,145
Dividend Yield 7.20%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround ↗
February 03, 2026
CarMax runs a nationwide network of used car stores and digital channels, offering multi-channel sales and financing to U.S. consumers. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter. ↗
February 03, 2026
This clinical-stage biotech develops therapies targeting autoimmune and neuroinflammatory diseases with a focus on TYK2 inhibition. 
Via The Motley Fool

Performance

YTD
+19.2%
+19.2%
1 Month
+17.2%
+17.2%
3 Month
+52.2%
+52.2%
6 Month
+66.8%
+66.8%
1 Year
+60.6%
+60.6%

More News

Read More
News headline image
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
January 13, 2026
From Lifeward Ltd.
Via GlobeNewswire
News headline image
Congressional Trading Report: Rep. Brad Knott Sold Over $15K In Oramed Pharmaceuticals Stock ↗
February 26, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
October 06, 2025
Via Benzinga
News headline image
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
April 28, 2025
From Alpha Tau Medical Ltd.
Via GlobeNewswire
News headline image
Unusual volume stocks in Wednesday's session ↗
February 12, 2025
Via Chartmill
News headline image
What's going on in today's session ↗
February 11, 2025
Via Chartmill
News headline image
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q2 2024 ↗
August 19, 2024
Via InvestorPlace
News headline image
3 Micro-Cap Moonshots for Fearless Investors ↗
July 08, 2024
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
June 12, 2024
Via Benzinga
News headline image
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q1 2024 ↗
May 09, 2024
Via InvestorPlace
News headline image
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q4 2023 ↗
March 07, 2024
Via InvestorPlace
News headline image
Top 4 Health Care Stocks That May Crash This Quarter ↗
February 02, 2024
Via Benzinga
News headline image
Week In Review: Mundipharma Considers $1 Billion Sale Of China Operations ↗
August 05, 2023
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
June 23, 2023
Via Benzinga
News headline image
Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
June 23, 2023
Via Benzinga
News headline image
Dow Tumbles 250 Points; CarMax Posts Upbeat Results ↗
June 23, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
May 16, 2023
Via Benzinga
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) Making Surprising Moves in Tuesday Session
May 16, 2023
Via Investor Brand Network
News headline image
Why Oramed Pharmaceuticals Shares Are Trading Higher Today ↗
May 15, 2023
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
January 19, 2023
Via Benzinga
News headline image
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
May 15, 2023
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
January 17, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023 ↗
January 17, 2023
Via Benzinga

Frequently Asked Questions

Is Oramed Pharmaceuticals Inc. - Common Stock publicly traded?
Yes, Oramed Pharmaceuticals Inc. - Common Stock is publicly traded.
What exchange does Oramed Pharmaceuticals Inc. - Common Stock trade on?
Oramed Pharmaceuticals Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Oramed Pharmaceuticals Inc. - Common Stock?
The ticker symbol for Oramed Pharmaceuticals Inc. - Common Stock is ORMP on the Nasdaq Stock Market
What is the current price of Oramed Pharmaceuticals Inc. - Common Stock?
The current price of Oramed Pharmaceuticals Inc. - Common Stock is 3.470
When was Oramed Pharmaceuticals Inc. - Common Stock last traded?
The last trade of Oramed Pharmaceuticals Inc. - Common Stock was at 02/04/26 02:25 PM ET
What is the market capitalization of Oramed Pharmaceuticals Inc. - Common Stock?
The market capitalization of Oramed Pharmaceuticals Inc. - Common Stock is 112.82M
How many shares of Oramed Pharmaceuticals Inc. - Common Stock are outstanding?
Oramed Pharmaceuticals Inc. - Common Stock has 113M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap